---
title: "Oncology Generic Medicines - Additions"
ocid: "ocds-r6ebe6-0000616887"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000616887"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000616887.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000616887.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2020-07-24"
---

# Oncology Generic Medicines - Additions

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-r6ebe6-0000616887

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000616887)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000616887.json)

## Summary

The Common Services Agency, commonly known as NHS National Services Scotland (NSS), is conducting a procurement process titled "Oncology Generic Medicines - Additions" in the healthcare industry, specifically focusing on the supply of oncology generic medicines. This procurement is currently in the Award stage, with the contract value estimated at approximately £14,878,505. The deadline for tender submission was previously set for 14 May 2020, following an extension that postponed the original date due to COVID-19 related workload challenges. Edinburgh, UK serves as the geographical location for this procurement, which employs an open procedure for the procurement method.

This tender presents significant opportunities for pharmaceutical companies, particularly those specialising in oncology products, generic medicines, or healthcare supply chains. Businesses that can demonstrate compliance with UK Marketing Authorisations and possess relevant quality certifications, such as ISO 9001, will be well-positioned to compete for the awarded contracts. With multiple lots available, including the supply of octreotide vials and dasatinib tablets, suppliers of varied sizes could explore possibilities for both direct supply and collaboration with NHS Scotland, enhancing their market presence in the healthcare sector.

## Notice

Supply of oncology generic medicines to NHS Scotland

### Lot Information

Octreotide Vials (Excluding Homecare)

Supply of octreotide vials (excluding homecare) to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework to two (2) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Octreotide Vials (Including Homecare)

Supply of octreotide vials (including homecare) to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework to two (2) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Dasatinib Tablets

Supply of dasatinib tablets to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier framework to two (2) Framework Participants.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Azacitidine Vials and Erlotinib Tablets

Supply of azacitidine vials and erlotinib tablets to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per line.

Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL390909 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 24 Jul 2020 |
| Submission deadline | 14 Apr 2020 |
| Future notice date | Not specified |
| Award date | 7 Jul 2020 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £14,878,505 |
| Lots value | £14,878,505 |
| Awards value | Not specified |
| Contracts value | £10,731,362 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 7 |
| Supplier names | ACCORD HEALTHCARE; BRISTOL-MYERS SQUIBB PHARMACEUTICALS; DR REDDY'S LABORATORIES (UK; GLENMARK PHARMACEUTICALS EUROPE; NOVARTIS PHARMACEUTICALS; TEVA; ZENTIVA PHARMA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 24 Jul 2020 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL390909
- 9 Apr 2020 at 00:00 - TenderUpdate - OJEU - F14 - Corrigendum - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR385095
- 12 Mar 2020 at 00:00 - TenderUpdate - OJEU - F14 - Corrigendum - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR383693
- 10 Mar 2020 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR383398

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR383398
  Oncology Generic Medicines - Additions - Supply of oncology generic medicines to NHS Scotland
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL390909
  Oncology Generic Medicines - Additions - Supply of oncology generic medicines to NHS Scotland

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- http://www.publictendersscotland.publiccontractsscotland.gov.uk
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000616887
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000616887. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000616887.json.